Universidade De Santiago De Compostela — Clinical Trial Site

26 Registered trials

12 Currently recruiting

Organisation

Universidade De Santiago De Compostela

Location

Santiago De Compostela, Spain

Identifier

ORG-100031435

Address

Rua Da Choupana Sn, 15706, Spain

Departments

Cardiology
Departamento de hematologia
Digestive medicine
Internal Medicine
Jefe del Servicio de Reumatología
Medical Oncology
N/A
Neumology
Neurology
Oncología
Oncology
Pediatric
Physical Medicine and Rehabilitation. Complexo Hospitalario Universitario de Santiago
Servicio de Cardiologia
Servicio de Neumología
Servicio de Oncología Médica
Unidad de Hematología y Oncología Infantil
Unit for Diagnosis and Treatment of Metabolic Diseases

Clinical trials at this site (26)

Search interface

Feasibility study of Neo-adjuvant (before surgery) versus Adjuvant (after surgery) chemotherapy in Upper Tract Urothelial Carcinoma Under evaluation

2024-514991-41-01 Upper Tract Urothelial Carcinoma. Upper urinary tract t 4
SIOP PNET 5 medulloblastoma Pending

2024-513724-42-00 Medulloblastoma 10
A Ph2 Superiority Study with InO Monotherapy vs ALLR3 for Induction Treatment of Childhood HR ALL Recruiting

2023-509810-13-00 Acute Lymphoblastic Leukemia (ALL) 4 2023-05-13
A Phase 3 Study of JNT-517 in Participants with Phenylketonuria Recruiting

2024-519554-37-00 Phenylketonuria 5 2026-01-16
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants with Atherosclerotic Cardiovascular Disease and … Recruiting

2024-516652-18-00 Atherosclerotic cardiovascular disease (ASCVD) and obes 5 2025-10-10
Role of Pancreatic Enzyme Replacement Therapy (PERT) (Creon®) for Pancreatic Exocrine Insufficiency (PEI) after Pancreatic Surgery Recruiting

2024-512798-29-00 Male and female patients aged ≥ 18 to ≤ 85 years with a 5 2025-01-07
Use of statins in patients with intracerebral hemorrhage Recruiting

2024-511465-11-00 Spontaneous lobar ICH 5 2024-11-20
GSDIa Disease Monitoring Program Recruiting

2023-510219-20-00 Glycogen storage disease type Ia (GSDIa) 11 2024-11-04
A follow-up study to test long-term treatment with BI 1015550 in people with pulmonary fibrosis who took part in a previous study with BI 10… Recruiting

2023-507353-15-00 idiopathic pulmonary fibrosis (IPF) 5 2024-09-10
A Phase 3, Randomized, Open-Label Study of Combination Therapy with Avutometinib plus Defactinib Versus Investigator’s Choice of Treatment i… Recruiting

2023-508204-38-00 Recurrent Low-Grade Serous Ovarian Cancer (LGSOC) 5 2024-07-02
A study investigating single injection of new botulinum toxin to determine safety and efficacy for treating spasticity in the upper limb Recruiting

2023-507202-14-00 Upper limb spasticity after stroke or traumatic brain i 7 2021-04-29
Phase 2 Study of Adagrasib Monotherapy and in Combination With Pembrolizumab and Phase 3 Study of Adagrasib in Combination with Pembrolizuma… Recruiting

2023-508922-83-00 Advanced Non-Small Cell Lung Cancer 10 2021-03-17
Teicoplanin as Infection Prophylaxis in Pediatric Acute Myeloid Leukemia (Pro-Teico study) Recruiting

2023-506546-23-00 Acute myeloid leukemia 5 2020-05-20
A Phase II Open-Label Study of Sacituzumab Govitecan in Unresectable Locally Advanced/Metastatic Urothelial Cancer Recruiting

2023-508302-24-00 Locally Advanced/Metastatic Urothelial Cancer 4 2019-05-07
Proof of Concept trial with CIT-013 in Rheumatoid Arthritis Ended

2024-517356-35-00 Moderately Active Rheumatoid Arthritis 4 2025-07-29
Role of Pancreatic Enzyme Replacement Therapy (PERT) (Creon®) in Pancreatic Exocrine Insufficiency (PEI) due to gastrectomy. Ended

2023-507837-18-00 Male and female patients aged ≥ 18 to ≤ 80 after total 6 2025-03-06
Trial to Evaluate Acasunlimab and Pembrolizumab Combination Superiority Over Standard of Care Docetaxel in Non-Small Cell Lung Cancer Ended

2024-512998-27-00 Non-Small Cell Lung Cancer 5 2025-02-21
A Phase 3 Study of DB-1303 vs Investigator's Choice Chemotherapy in HER2-low, Hormone Receptor Positive, Metastatic Breast Cancer Ended

2023-507333-17-00 HER2-low, Hormone Receptor Positive, Metastatic Breast 5 2024-04-15
Study of Acalabrutinib Plus Venetoclax and Rituximab in Participants with Treatment Naïve Mantle Cell Lymphoma Ended

2023-505205-16-00 Treatment Naïve Mantle Cell Lymphoma 4 2024-02-21
TALAPRO 2: A PHASE 3, RANDOMIZED, DOUBLE BLIND, PLACEBO-CONTROLLED STUDY OF TALAZOPARIB WITH ENZALUTAMIDE IN METASTATIC CASTRATION RESISTANT… Ended

2023-509087-20-00 Metastatic Castration-resistant Prostate Cancer 5 2019-04-16
Endocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in Participants With Breast Cancer (monarchE) Ended

2023-509671-17-00 Breast Cancer 5 2017-07-12
MLS-101-301: A Randomized, Double-Blind, Placebo Controlled, Parallel Arm, Multicenter Phase 3 Study to Evaluate the Efficacy and Safety of … Ended

2023-506425-12-00 Uncontrolled and Resistant Hypertension 5 2024-04-17
A Phase 2 Study of the Effects of Ponsegromab on Health-Related Quality of Life and Safety in Patients With Heart Failure (GARDEN-TIMI 74) Ended

2023-509747-27-00 Heart failure 4 2023-05-18
A study to find out whether BI 1015550 improves lung function in people with Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs) Ended

2024-512803-37-00 Progressive Fibrosing Interstitial Lung Diseases (PF-IL 5 2022-10-05